Real-World data sheds light on bladder cancer treatment
NCT ID NCT05366725
Summary
This study observed how well the drug Avelumab worked in real-world settings for adults with advanced bladder cancer. It included 106 patients whose cancer had not worsened after initial chemotherapy and who then received Avelumab as a standard maintenance therapy. The goal was to collect information on survival, side effects, and treatment patterns to better understand the drug's real-world performance.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beatson West of Scotland Cancer Centre
Glasgow, G12 0YN, United Kingdom
-
Churchill Hospital
Oxford, OX3 7LE, United Kingdom
-
Clatterbridge Hospital
Metropolitan Borough of Wirral, CH63 4JY, United Kingdom
-
Guy's and St Thomas' Hospital
London, SE1 9RT, United Kingdom
-
Lister Hospital
Stevenage, SG1 4AB, United Kingdom
-
Royal Preston Hospital
Preston, PR2 9HT, United Kingdom
-
Royal Surrey County Hospital
Guildford, GU2 7XX, United Kingdom
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
University College London Hospital
London, NW1 2PG, United Kingdom
-
University Hospitals Bristol
Bristol, BS1 3NU, United Kingdom
Conditions
Explore the condition pages connected to this study.